Clinical trial
Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
NCT00091299 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00091299 |
|---|---|
| Title | Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors |
| Official title | An Open Label, Non Randomized , One Sequence, Add-On Study to Investigate the Effects of PTK787/ZK 222584 on the Pharmacokinetics and Pharmacodynamics of Warfarin at Steady-States in Cancer Patients |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | warfarin |
| Enrollment | 24 |
| Start date | May 1, 2004 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Sep 9, 2004 |
| Last update posted | Aug 5, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: